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Abstract
Background: Clinicians frequently prescribe antibiotics inappropriately for acute respiratory infections (ARIs). Our
objective was to test information technology-enabled behavioral interventions to reduce inappropriate antibiotic
prescribing for ARIs in a randomized controlled pilot test trial.
Methods: Primary care clinicians were randomized in a 2 × 2 × 2 factorial experiment with 3 interventions: 1)
Accountable Justifications; 2) Suggested Alternatives; and 3) Peer Comparison. Beforehand, participants completed
an educational module. Measures included: rates of antibiotic prescribing for: non-antibiotic-appropriate ARI
diagnoses, acute sinusitis/pharyngitis, all other diagnoses/symptoms of respiratory infection, and all three ARI
categories combined.
Results: We examined 3,276 visits in the pre-intervention year and 3,099 in the intervention year. The antibiotic
prescribing rate fell for non-antibiotic-appropriate ARIs (24.7 % in the pre-intervention year to 5.2 % in the
intervention year); sinusitis/pharyngitis (50.3 to 44.7 %); all other diagnoses/symptoms of respiratory infection (40.2
to 25.3 %); and all categories combined (38.7 to 24.2 %; all p < 0.001). There were no significant relationships
between any intervention and antibiotic prescribing for non-antibiotic-appropriate ARI diagnoses or sinusitis/
pharyngitis. Suggested Alternatives was associated with reduced antibiotic prescribing for other diagnoses or
symptoms of respiratory infection (odds ratio [OR], 0.62; 95 % confidence interval [CI], 0.44–0.89) and for all ARI
categories combined (OR, 0.72; 95 % CI, 0.54–0.96). Peer Comparison was associated with reduced prescribing for all
ARI categories combined (OR, 0.73; 95 % CI, 0.53–0.995).
Conclusions: We observed large reductions in antibiotic prescribing regardless of whether or not study participants
received an intervention, suggesting an overriding Hawthorne effect or possibly clinician-to-clinician contamination.
Low baseline inappropriate prescribing may have led to floor effects.
Trial Registration: ClinicalTrials.gov: NCT01454960.
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Background
Viruses cause the vast majority of acute respiratory in-
fections (ARIs), yet antibiotics remain widely prescribed
[1–3]. Inappropriate antibiotic use may lead to adverse
drug events, greater cost, and the spread of resistant or-
ganisms [4–6].
Interventions to reduce antimicrobial prescribing such
as physician and patient education, physician audit and
feedback, clinical decision support and financial or regu-
latory incentives have been modestly effective at redu-
cing inappropriate antibiotic prescribing, generally
producing approximately 10 % reductions in antibiotic
prescribing rates [7–9]. Educational interventions may
have limited impact on prescribing rates when lack of
guideline awareness is not the primary reason for in-
appropriate antibiotic prescribing [10].
Recognizing the limitations of educational and infor-
mational interventions, we developed several interven-
tions that draw on insights from behavioral economics
and social psychology [11]. These are designed to appeal
to clinician self-image and social motivation. Our inter-
ventions take into account a growing body of research
indicating that individuals’ cognitive limitations and so-
cial motivations often give rise to systematic biases that
violate standards of rational behavior [12–15]. Here we
report the findings of a single-site clinician-randomized
controlled trial that was performed in preparation for a
larger multi-site trial [16].
Methods
Objectives
The objective of the study was to pilot test three inter-
ventions to improve guideline-concordant antibiotic pre-
scribing as a precursor to inform development of a
larger national cluster randomized trial (ClinicalTrials.-
gov Identifier: NCT01454947) [11]. The Northwestern
Medical Faculty Foundation (NMFF) General Internal
Medicine clinic was selected as the pilot site prior to a
larger trial conducted in three other organizations for
two reasons: first, the NMFF site, with a single clinic,
could not accommodate a cluster-randomized trial (with
randomization at the clinic level); second, the NMFF site
was able to start the trial earlier than the other sites,
which permitted pilot testing of the chosen interventions
and optimization of study procedures.
The institutional review boards of Northwestern Uni-
versity and the University of Southern California ap-
proved the study. The trial registration identifier is
NCT01454960 at ClinicalTrials.gov. The study protocol
is available from the corresponding author by request.
Setting and participants
The NMFF General Internal Medicine clinic is a large
adult primary care practice affiliated with an academic
medical center and located in Chicago, Illinois. The prac-
tice uses the EpicCare electronic health record (EHR; Epic
Systems Corp., Verona, WI) for all clinical documentation
and for all prescribing. All attending physicians and nurse
practitioners were eligible for recruitment (excluding SDP,
a study investigator). Clinicians provided written informed
consent before randomization. Payment for study partici-
pation was up to $300 per clinician per month of partici-
pation, regardless of intervention assignment (clinicians
with less than full-time clinic work schedules were paid
proportionally less). De-identified data from qualifying pa-
tient visits that occurred with enrolled clinicians were
used in the analyses with an institutional review board
waiver of consent.
Baseline survey and education
On enrollment, we asked all participating clinicians to
complete a 15 to 20 min online survey that included
questions about attitudes regarding antibiotic prescrib-
ing and an educational module containing information
about ARI treatment guidelines [17–20]. The module
also described the interventions to which the clinician
was assigned, including changes they would observe in
their EHR (for Accountable Justifications and Suggested
Alternatives interventions) and examples of the kinds of
emails they would receive (Peer Comparison). Brief de-
scriptions of the interventions are provided below; de-
tails are available elsewhere [11].
Interventions
Accountable justifications intervention
Clinicians randomized to “Accountable Justifications” re-
ceived EHR alerts in the course of e-prescribing an anti-
biotic for an ARI diagnosis (listed in the Additional file
1: Table S1). The alert briefly summarized the treatment
guidelines corresponding to the ARI diagnosis for which
the antibiotic was being written (e.g., “antibiotics are not
indicated for non-specific upper respiratory infections”),
prompted the clinician to enter a free-text justification
for prescribing an antibiotic, and informed the clinician
that the free-text justification provided would be in-
cluded in the patient’s medical record where it would be
visible to other clinicians. Clinicians were also informed
that if no free-text justification was entered, a default
statement “No justification for prescribing antibiotics
was given” would appear in the record. If the antibiotic
order was canceled, no justification was required, and no
default text appeared.
These alerts were suppressed for patients whose EHR
problem lists contained comorbid chronic conditions
that exempted these patients from clinical guidelines
(e.g. chronic obstructive pulmonary disease, heart failure,
cirrhosis). The lists of diagnoses we used to suppress
study-related clinical decision support were similar to
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those published in the supplement to the article describ-
ing the methods for the multi-site study [11].
This intervention draws from prior studies that show
accountability improves decision making accuracy, and
that public justification engenders reputational concerns.
We expected that the potential to have their non-
guideline-concordant choices displayed to others would
make clinicians more likely to act in accordance with in-
junctive norms (guideline recommendations) [21–26].
Suggested alternatives intervention
When clinicians assigned to the Suggested Alternatives
intervention entered an ARI diagnosis for a patient visit, a
computerized alert presented an order set containing mul-
tiple non-antibiotic prescription and non-prescription
medication choices as well as educational materials that
could be printed and given to the patient [11]. We de-
signed these order sets to include many of the most com-
mon non-antibiotic treatments used to treat ARI
symptoms. This intervention draws from the behavioral
insight that the presentation of (non-antibiotic) alterna-
tives may lead clinicians to infer that these suggestions
ought to be considered and this will lead to a reduced
chance that an antibiotic will be prescribed [27].
Peer comparison intervention
Clinicians in the Peer Comparison Intervention group
received emailed monthly performance feedback reports.
These reports included the clinician’s individual anti-
biotic prescribing rates for non-antibiotic-appropriate
ARIs and as a benchmark, the antibiotic prescribing rate
for clinicians who were at the 10th percentile within the
clinic (i.e., those with the lowest rates of inappropriate
antibiotic prescribing). These rates were calculated based
on the most recent 20 eligible visits excluding encoun-
ters occurring with patients who had certain comorbidi-
ties or other diagnosed bacterial infections [11].
If clinicians were among the 10 % of their peers with
the “best”—i.e. lowest— prescribing rates the emailed re-
ports told clinicians "You are a top performer.” If clini-
cians were not among the 10 % best, the emailed report
told clinicians “You are not a top performer. You are
prescribing too many unnecessary antibiotics.” The pro-
portion of “Top Performers” could be greater than 10 %
of clinicians if more than 10 % of clinicians had an in-
appropriate antibiotic prescribing rate of zero.
These peer comparisons were designed to differ from
traditional audit and feedback by showing comparisons
to top-performing instead of average-performing peers,
and its delivery of positive reinforcement to current top-
performers. This strategy has been previously shown to
help sustain high performance [28–30].
Experimental design and randomization
We performed a 2 × 2 × 2 factorial randomized trial, with
one arm for each possible combination of the three in-
terventions, corresponding to the eight rows shown in
Table 2. We randomized all clinicians at once in two
blocks by number of qualifying visits in the prior year to
ensure relatively balanced allocation, then assigned each
to an intervention group using a random number gener-
ator in SAS 9.3 (SAS Institute Inc., Cary, NC) performed
by a researcher who was not aware of clinicians’ iden-
tities until after the randomization was completed [31].
Once the intervention began, participating clinicians
were not blinded to their study group assignments. Out-
come data was collected and assessed automatically
(with no human judgement) by applying identical cri-
teria to data collected using Structured Query Language
applied to EHR data.
Measures
We measured physician and nurse practitioner charac-
teristics during the initial online survey. We obtained
patient age, sex and race/ethnicity from EHR data.
Primary outcome
The primary study outcome was the rate of oral anti-
biotic prescribing during eligible study visits with non-
antibiotic-appropriate ARI diagnoses (listed Additional
file 1: Table S1). An office visit was eligible for inclusion
in the outcome denominator if: 1) the patient was
18 years old or older, 2) the clinician was enrolled in the
study, 3) the visit occurred during the 12-month inter-
vention period from February 2012 through January,
2013, and 4) the patient did not have a visit with an ARI
diagnosis in the prior 30 days. We excluded visits from
the primary analysis when: 1) patients had certain med-
ical co-morbidities that make ARI guidelines less likely
to apply; 2) patients had concomitant visit diagnoses in-
dicating a possible non-ARI bacterial infection or reason
for antibiotic prescribing; or 3) patients had concomitant
visit diagnoses indicating potentially antibiotic-
appropriate ARI diagnoses or other ARI diagnoses sug-
gestive of a bacterial infection. The sets of diagnoses
used to determine eligibility and calculate the outcomes
were similar to those we reported previously [11].
Secondary outcomes
Secondary outcomes included the rates of oral antibiotic
prescribing for three other groups of qualifying visits: 1)
visits with diagnoses for potentially-antibiotic-
appropriate ARI diagnoses (acute sinusitis and acute
pharyngitis; Additional file 1: Table S1); 2) visits with
diagnoses also potentially indicating an ARI (e.g., pneu-
monia, cough; Additional file 1: Table S1); and 3) the
rate of antibiotic prescribing for the sum of visits
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included in the primary outcome and these two second-
ary outcomes (all diagnosis categories combined). We
applied the same additional inclusion and exclusion cri-
teria above to these secondary diagnoses as we did to
the primary outcome. We examined the distribution of
visits in each of these 3 categories during the interven-
tion year and the year prior to look for “diagnosis shift-
ing” through which clinicians could be more likely to
select antibiotic-appropriate diagnoses to conceal an un-
changed overall antibiotic prescribing rate.
Safety monitoring
In order to ensure that interventions did not cause in-
appropriate under-prescribing of antibiotics, we exam-
ined the records of all patients who had return visits
with a diagnosis indicative of a bacterial respiratory tract
infection within 30 days of a qualifying visit for a non-
antibiotic-appropriate diagnosis, a potentially-antibiotic-
appropriate diagnosis, or cough. In cases where an anti-
biotic was not prescribed at the index visit, a physician
(SDP) blinded to clinician intervention group judged
whether: 1) an antibiotic was prescribed within 24 h
without the patient having to reinitiate contact (e.g.
physician called the patient and prescribed an antibiotic
in response to an abnormal chest x-ray), 2) an antibiotic
was not prescribed and it seemed unlikely that an anti-
biotic at the index visit would have improved the clinical
course, or 3) an antibiotic was not prescribed and it may
have been clinically useful had an antibiotic been pre-
scribed. An independent data safety and monitoring
board reviewed this data during the study.
Statistical analysis
The effects of the study interventions were assessed
using separate mixed logistic regression models for
each of the primary and secondary outcomes that in-
cluded each of the three interventions and clinicians’
prior prescribing rate as fixed effects, and individual
clinicians as random effects (PROC GLIMMIX, SAS
9.3). We tested models with and without two-way
and three-way interaction terms between the inter-
ventions. Because including these interaction terms
had very little impact on the estimated effects of the
interventions and complicate the interpretation of the
results, we report results of models without inter-
action terms. Because this was intended as a pilot
study, no formal power analysis was conducted. Re-
sults are provided with 95 % confidence intervals.
In addition to the primary planned analyses, post hoc
we constructed models for each of the primary and sec-
ondary outcomes that included eligible visits during the
year prior to and the year during the intervention
period. We tested models that included a term for the
intervention year and also a continuous variable for time
to assess for evidence of temporal changes in antibiotic
prescribing rates.
We performed post hoc analyses that included data
from the 10 physicians working in the same practice
who did not participate in the randomized trial during
the year prior to and the year during the intervention
period to determine if their antibiotic prescribing rates
during these two years differed significantly from the cli-
nicians who participated in the study.
Results
Of the 37 internists and 1 nurse practitioner approached,
27 internists and the nurse practitioner enrolled in the
trial (74 %). Participating clinicians were 39 male, 61
white, 36 Asian and 4 % African American. Most (75 %)
were over 40 years of age. The average number (standard
deviation) of distinct patients seen by a participating
clinician was 905 (483) in the pre-intervention year and
923 (543) in the intervention year. The flow of partici-
pants through the trial is shown in the Additional file 2:
Figure S1. Of all visits made to participating clinicians in
the pre-intervention year, 7.2 % were eligible ARI visits
analyzed for any of the study outcomes. In the interven-
tion year 7.7 % were eligible ARI visits. Patients’ demo-
graphic characteristics are provided in Table 1.
The number of clinicians randomized to the different
intervention assignments is shown in Table 2 along with
the number of eligible study visits with a non-antibiotic-
appropriate ARI diagnosis during the year prior to the
study and the year during the study. Additional details
of are provided in the study flow diagram (Additional
file 2: Figure S1). Participating physicians prescribed an-
tibiotics in 24.7 % of visits for non-antibiotic-appropriate
ARI diagnoses in the year prior to the trial and in 5.2 %
of such visits during the year of the trial (Table 2). Cor-
responding results for the secondary outcomes are pro-
vided in Additional file 1: TablesS2, S3 and S4. None of
the three interventions significantly lowered (or raised)
rates of antibiotic prescribing for visits with non-
antibiotic-appropriate diagnoses (Table 3). However, for
visits with other ARI diagnoses and symptoms, the Sug-
gested Alternatives intervention was associated with sig-
nificantly lower odds of antibiotic prescribing (odds ratio
[OR], 0.62; 95 % confidence interval [CI], 0.44–0.89).
The Suggested Alternatives and Peer Comparisons inter-
ventions were associated with lower odds of antibiotic
prescribing for the all ARI diagnoses combined—OR
0.72 (CI 0.54–0.96) and OR 0.73 (CI 0.53–0.995), re-
spectively. The clinician’s prescribing rate in the pre-trial
year was strongly associated with the antibiotic prescrib-
ing rate during the trial year for each outcome examined
(Table 3).
Table 4 shows the distribution of eligible visits among
the three different diagnosis categories we examined in
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the pre-trial year and the trial year. There were similar
total numbers of eligible study visits in each year (3276
in the pre-trial year and 3099 in the trial year). There
was no suggestion of diagnosis shifting in the selection
of diagnosis codes during the study.
In the mixed regression models, antibiotic prescrib-
ing was substantially and significantly lower during
the intervention year compared to the pre-
intervention year across all categories, and the con-
tinuous variable for time (study quarter, used to as-
sess for an underlying temporal trend in antibiotic
prescribing) was not significant in any of the four
models examined except for a slight increase in pre-
scribing rate over time for possibly-antibiotic-
Table 2 Results of clinician randomization and the primary outcome
Intervention Randomized
Clinicians (n)
Antibiotic Prescribing
for Visits with Non-Antibiotic-Appropriate
ARI Diagnoses
Difference in
Antibiotic Prescribing
Rate between
Intervention and Pre-
intervention Period %
(95 % CI)
Pre-Intervention Year, n/
N (%)
Intervention Year, n/N
(%)
No intervention 4 7 / 57 (12.3) 5 / 136 (3.4) −8.6 (−17.9 to 0.7)
Accountable Justifications 3 14 / 72 (19.4) 8 / 70 (11.4) −8.0 (−20.0 to 4.0)
Suggested Alternatives 3 7 / 44 (15.9) 4 / 51 (7.8) −8.1 (−21.5 to 5.4)
Peer Comparisons 3 31 / 74 (41.9) 8 / 68 (11.8) −30.1 (−44.0 to −16.3)
Accountable Justifications, Suggested Alternatives 4 20 / 128 (15.6) 2 / 95 (2.1) −13.5 (−20.5 to −6.5)
Suggested Alternatives, Peer Comparisons 4 41 / 118 (34.8) 4 / 102 (3.9) −30.8 (−40.3 to −21.3)
Accountable Justifications, Peer Comparisons 4 44 / 187 (23.5) 6 / 206 (2.9) −20.6 (−27.2 to −14.1)
Accountable Justifications, Suggested Alternatives, Peer
Comparisons
3 46 / 171 (26.9) 9 / 162 (5.6) −21.4 (−28.9 to −13.8)
Any Accountable Justifications 14 124 / 558 (22.2) 25 / 532 (4.7) −17.5 (−21.4 to −13.6)
No Accountable Justifications 14 86 / 293 (29.4) 21 / 357 (5.9) −23.5 (−29.3 to −17.7)
Any Suggested Alternatives 14 114 / 461 (24.7) 19 / 410 (4.6) −20.1 (−24.5 to −15.7)
No Suggested Alternatives 14 96 / 390 (24.6) 27 / 479 (5.6) −19.0 (−23.7 to −14.2)
Any Peer Comparisons 14 162 / 550 (29.5) 27 / 537 (5.0) −24.4 (−28.7 to −20.2)
No Peer Comparisons 14 48 / 301 (15.9) 19 / 352 (5.4) −10.6 (−15.3 to −5.8)
All groups combined 28 210 / 851 (24.7) 46 / 889 (5.2) −19.5 (−22.8 to −16.3)
ARI acute respiratory infection, CI confidence interval
Table 1 Demographic characteristics of patients seen by participating clinicians
All Patients Patients Included in Study Analyses
Pre-intervention Intervention Pre-intervention Intervention
Year Year Year Year
Age, mean (SD) 48.7 (16.7) 49.4 (16.9) 46.6 (16.2) 47.7 (16.3)
Sex, n (%)
Male 7269 (36.2) 7469 (36.6) 904 (32.2) 888 (33.1)
Female 12798 (63.8) 12950 (63.4) 1907 (67.8) 1791 (66.9)
Race/Ethnicity, n (%)
White, non-Hispanic 9460 (47.1) 9659 (47.3) 1384 (49.2) 1244 (46.4)
Black 3706 (18.5) 3806 (18.6) 422 (15) 444 (16.6)
Hispanic 1380 (6.9) 1457 (7.1) 201 (7.2) 204 (7.6)
Asian 974 (4.9) 1056 (5.2) 121 (4.3) 129 (4.8)
American Indian/Pacific Islander 42 (0.2) 50 (0.2) 11 (0.4) 9 (0.3)
More than one race 359 (1.8) 414 (2) 52 (1.8) 58 (2.2)
Other 1481 (7.4) 1524 (7.5) 213 (7.6) 225 (8.4)
Unknown 2665 (13.3) 2453 (12) 407 (14.5) 366 (13.7)
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appropriate diagnoses (odds ratio [OR] per calendar
quarter: 1.11 [1.03–1.20]; Table 5; Fig. 1).
In the post hoc analysis, non-participating physicians
prescribed antibiotics in 35.3 % of visits for non-
antibiotic-appropriate ARI diagnoses in the year prior to
the trial and in 28.6 % of such visits during the year of
the trial. For all ARI diagnoses combined, prescribing
rates for non-participants during these two years were
49.6 % and 46.2 %, respectively. In multivariable regres-
sion models, non-participants’ prescribing rates were not
significantly different from those of study participants
during the year prior to the intervention but were sig-
nificantly higher than study participants during the trial
period. The OR for prescribing antibiotics for non-
antibiotic-appropriate ARI visits during the trial period
for non-participants compared to participants was 4.99
(2.35–10.6), and for all ARI diagnoses combined OR
1.70 (1.31–2.21).
In the safety monitoring analyses, we analyzed 18 return
visits (0.74 %) with a diagnosis of a bacterial respiratory
tract infection that occurred within 30 days of a qualifying
study visit at which an antibiotic was not prescribed. Of
these, 7 of these received antibiotics within 24 h of the
qualifying visit without the patient having to reinitiate
contact. In 3 cases, it seemed unlikely that an antibiotic
would have improved the course of illness if prescribed at
the initial visit. In 8 cases (0.31 %), an antibiotic was not
prescribed and may have been clinically useful had it been
prescribed at the index visit. None of these 8 patients died
or had a prolonged hospitalization. These visits were
evenly distributed across the intervention groups
(Additional file 1: Table S5).
Discussion
This pilot study tested three interventions drawing on so-
cial psychology and behavioral economic principles. This
initial test of these interventions helped inform the con-
duct of a larger, multi-site trial [16], and also led to several
interesting observations. The study resulted in large re-
ductions in antibiotic prescribing at adult outpatient visits
for acute respiratory infections in a large primary care
practice compared to the year before the study began.
Table 3 Intervention effects on primary and secondary outcomes
Accountable
justifications
Suggested
alternatives
Peer comparisons Clinician’s prior year prescribing
rate (per 10 % increase)
Odd ratios (95 % confidence intervals) for antibiotic prescribing
Antibiotic for non-antibiotic appropriate
ARI diagnoses (primary outcome)
0.98 (0.42–2.29) 0.68 (0.29–1.58) 0.45 (0.18–1.11) 1.57 (1.15–2.13)*
Antibiotic for potentially antibiotic
appropriate ARI diagnoses
0.77 (0.42–1.41) 0.57 (0.31–1.05) 1.14 (0.59–2.19) 1.71 (1.23–2.36)*
Antibiotic for other ARIs diagnoses or
symptoms of interest
1.29 (0.92–1.80) 0.62 (0.44–0.89)** 0.70 (0.48–1.02) 1.40 (1.25–1.57)**
Antibiotic for all three combined 1.05 (0.80–1.39) 0.72 (0.54–0.96)*** 0.73 (0.53–0.995)**** 1.64 (1.45–1.84)***
ARI acute respiratory infection
*p < .005
**p < .01
***p < .001
****p < 0.05
Table 4 Antibiotic prescribing for eligible visits with all potential ARI diagnoses, pre-intervention year and intervention year
Diagnosis Category Year prior to intervention Intervention year
% of ARI visits in
diagnosis
category
Number visits
given
antibiotic
Number
eligible
visits
Percentage
prescribed
antibiotic
% of ARI visits in
diagnosis
category
Number visits
given
antibiotic
Number
eligible
visits
Percentage
prescribed
antibiotic
Non-Antibiotic
Appropriate ARI
Diagnoses
26.0 210 851 24.7 28.7 46 889 5.2
Potentially Antibiotic
Appropriate ARI
Diagnoses
24.9 411 817 50.3 24.3 336 752 44.7
Other ARIs Diagnoses
or Symptoms of
Interest
49.1 646 1608 40.2 47.0 369 1458 25.3
All diagnoses
combined
100 1267 3276 38.7 100 751 3099 24.2
ARI acute respiratory infection
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Reductions in antibiotic prescribing occurred both for cli-
nicians receiving one or more active interventions and
those assigned to the control condition (but not among
physicians who declined to participate). The decline in
prescribing occurred in all diagnosis categories examined
and was most dramatic for visits with non-antibiotic-
appropriate diagnoses (a decline of 19.5 %). During the
intervention year, receipt of our interventions did not sig-
nificantly affect antibiotic prescribing at visits with non-
antibiotic-appropriate diagnoses. Two of the interven-
tions, Suggested Alternatives and Peer Comparisons,
yielded significantly lower rates of antibiotic prescribing
for the secondary outcome of all the diagnostic categories
combined. Compared to our larger, clinic-randomized
trial, the overall reduction in antibiotic prescribing ob-
served here was similar. Notable differences between that
study and the one presented here are that in the larger
study—which had greater statistical power—accountable
justifications and peer comparisons led to significantly
greater reductions in antibiotic prescribing at non-
antibiotic-appropriate ARI visits [16].
The magnitude of the reduction in antibiotic prescrib-
ing observed from the pre-study year to the study year
was larger than what has generally been observed in
prior studies aimed at reducing antibiotic prescribing in
ARIs. For instance, Gonzales and colleagues recently ob-
served 12 to 13 % declines in antibiotic prescribing for
acute bronchitis at intervention sites given computerized
or printed decision support for acute cough illnesses and
a small increase in antibiotic prescribing at control sites
[9]. Likewise, a systematic review of quality improve-
ment interventions aimed at reducing inappropriate
antibiotic use showed a median reduction in antibiotic
prescribing of 9.7 % (interquartile range 6.6—13.7 %) [7].
There are several possible explanations for our observed
findings of a large overall decline in prescribing with little
observable intervention-specific effects. First, clinicians’ en-
rollment in the study, completion of the on-line educational
module, receipt of a financial incentive to participate in the
study, and awareness that they were among a small group
having their antibiotic prescribing practices scrutinized may
have given rise to a fairly strong observer effect (or Haw-
thorne effect) even among clinicians assigned to the control
condition [32]. This phenomenon has been described
among pediatricians who had their antibiotic prescribing
behavior observed [33]. In fact, we expected the Peer Com-
parison and Accountable Justifications interventions to op-
erate partly through participants’ sensitivity to being
observed by others. Physicians within this practice were ac-
customed to having their performance measured for a var-
iety of clinical topics for quality improvement purposes
[34], and the observer effect may have been particularly
strong. Because the antibiotic prescribing rate among this
clinician group prior to the intervention year was already
lower than what has been reported in other studies [1, 2, 7],
the prescribing rate for the primary outcome may have
reached a floor so that adding additional interventions
could not reduce it further.
Table 5 Results of mixed effects models pre-intervention year and intervention yeara
Year prior to the intervention Calendar quarter
Odds Ratios (95 % confidence Intervals)
Antibiotic for non-antibiotic appropriate ARI diagnoses 6.34 (3.49–11.5)* 1.01 (0.90–1.14)
Antibiotic for potentially-antibiotic-appropriate ARI diagnoses 2.40 (1.69–3.42)* 1.11 (1.03–1.20)**
Antibiotic for other ARIs diagnoses or symptoms of interest 1.59 (1.10–2.29)*** 0.98 (0.90–1.06)
Antibiotic for all three combined 2.28 (1.83–2.83)* 1.03 (0.98–1.08)
ARI acute respiratory infection
*p < 0.001
**p <0.01
**p < 0.05
aModels predicting antibiotic prescribing include a pre-intervention year variable and a continuous variable for calendar quarter as fixed effects, and clinician as
random effects. Analyses are exploratory
Fig. 1 Percentage of eligible visits with antibiotic prescribed for
visits with non-antibiotic appropriate diagnoses and all ari diagnosis
categories combined by quarter. (Black Square) All eligible visits for
acute respiratory infections. (Gray Diamond) Eligible visits for non-
antibiotic-appropriate acute respiratory infections. Error bars represent
95 % confidence intervals. ARI: acute respiratory infection
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Second, contamination from working in close proxim-
ity to peers who received single or multiple interventions
related to antibiotic prescribing may have led clinicians
to reduce their prescribing more than they otherwise
would have. For example, learning that his colleague was
a “top performer” relative to a group that includes his
own performance may have instilled a sense of competi-
tion in a control participant. Such informational con-
tamination between conditions could have been due to
information concerning interventions, information about
antibiotic prescription rates and/or general conversation
about antibiotic over-prescribing. The fact that prescrib-
ing rates among non-participating physicians within the
same physical practice changed little and remained sub-
stantially greater than rates for study participants speaks
against this possibility.
Third, this study is limited by its sample size. This was
a fairly small pilot study meant to test procedures to be
employed in a larger multisite study [11]. The number of
eligible visits for the primary outcome was insufficient
to exclude clinically meaningful intervention effects on
the primary study outcome. Furthermore, because we
were testing the factorial design that was to be used in
the subsequent larger trial, there were only three or four
clinicians within each intervention assignment and only
four clinicians who received none of the interventions.
The small sample sizes probably account for highly vari-
able baseline antibiotic prescribing rates between groups.
Despite lack of statistical significance, we observed the
expected direction of effects, and the magnitude of ef-
fects in the Suggested Alternatives and Peer Comparison
interventions are promising.
Consistent with prior studies [10, 35, 36], we did not
observe any evidence that clinicians manipulated their
diagnostic coding away from non-antibiotic-appropriate
diagnoses toward those that would appear to more readily
justify the use of antibiotic or those that would not trigger
the clinical decision support interventions. This provides
reassurance that the changes in antibiotic prescribing rates
that we observed were real, and not merely caused by
changes in diagnosis selection.
We also observed a reduction in antibiotic prescrib-
ing at potentially-antibiotic-appropriate ARI visits
(which consist of acute sinusitis and pharyngitis).
These clinical syndromes are frequently caused by vi-
ruses, and our safety analysis showed very few pa-
tients returning within 30 days following a visit where
an antibiotic was not prescribed and it may have been
clinically useful had one been given. Therefore, we
think it is likely that the reduction in antibiotic use
in this diagnostic category was clinically appropriate.
An additional potential limitation is worth noting. The
baseline antibiotic prescribing rates among clinicians in
this group (both among clinicians who participated and
those who didn’t) were lower than what has been re-
ported in broader populations of clinicians [1–3]. This
suggests that these findings may not be generalizable to
other practice settings.
Conclusions
The conduct of this pilot study had a large impact on
antibiotic prescribing across all study physicians includ-
ing among control participants (but not among non-
participants within the same practice). The results of a
larger multisite trial conducted by this same study group
help address this study’s aforementioned limitations [16].
The large reductions in antibiotic prescribing we ob-
served even among control participants are interesting
and suggest that interventions designed with an
intentional observer effect could be particularly effective.
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